New Articles
  March 22nd, 2016 | Written by

France’s Eurofins Micro Locates Lab in Kentucky

[shareaholic app="share_buttons" id="13106399"]

Sharelines

  • Louisville location will Eurofins expedite lab turnarounds.
  • Microbiology lab is using “novel and specialized logistics” to provide fast results.
  • Fast lab results impacts food production schedules and companies' bottom lines.

Diagnostic testing services provider Eurofins Microbiology has opened a new, state-of-the-art, certified laboratory in Louisville, Kentucky.

The new facility offers the testing services needed to rapidly quantify, detect, or identify pathogenic, spoilage, and pro-biotic micro-organisms utilizing “novel and specialized logistics” to provide fast results when time to product release is critical,” the company said.

Due to Louisville’s proximity to over 60 percent of major U.S. cities, and being home to the UPS hub, the new location “will be one of the most efficient microbiology testing laboratories in the marketplace as increased logistical speed helps reduce the turnaround time of results by up to eight hours over competing laboratories,” it added.

“Our Eurofins ExpressMicro service enables us to provide customers a very quick time to result, without compromising method or process quality, said Mehgan Styke, business unit manager of Eurofins Microbiology in Louisville.

“As the time waiting to release product or review results often impacts food production schedules and the bottom line, it’s exciting to have both a local and nationwide food safety and testing solution that incorporates customized logistics and high quality testing solutions,” she added.

The Louisville laboratory “will follow the same quality standards that Eurofins is proud to incorporate across its many laboratories and divisions in the US,” Styke said.

France-headquartered Eurofins currently operates 225 testing laboratories in 39 countries, serving the food, environmental, agricultural, and pharmaceutical industries. Six, including the new Kentucky facility, are located in the U.S. In May 2015, it acquired U.S.-based QC Laboratories and Experchems in Canada as part of its long-term North American expansion strategy.

The company’s portfolio consists of more than 130,000 reliable analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products, as well as for innovative clinical diagnostic.